1. Home
  2. PRPO vs DSS Comparison

PRPO vs DSS Comparison

Compare PRPO & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • DSS
  • Stock Information
  • Founded
  • PRPO N/A
  • DSS 1984
  • Country
  • PRPO United States
  • DSS United States
  • Employees
  • PRPO N/A
  • DSS N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • DSS Containers/Packaging
  • Sector
  • PRPO Industrials
  • DSS Consumer Discretionary
  • Exchange
  • PRPO Nasdaq
  • DSS Nasdaq
  • Market Cap
  • PRPO 9.9M
  • DSS 7.3M
  • IPO Year
  • PRPO N/A
  • DSS N/A
  • Fundamental
  • Price
  • PRPO $7.22
  • DSS $0.95
  • Analyst Decision
  • PRPO
  • DSS
  • Analyst Count
  • PRPO 0
  • DSS 0
  • Target Price
  • PRPO N/A
  • DSS N/A
  • AVG Volume (30 Days)
  • PRPO 5.9K
  • DSS 18.3K
  • Earning Date
  • PRPO 03-28-2025
  • DSS 03-26-2025
  • Dividend Yield
  • PRPO N/A
  • DSS N/A
  • EPS Growth
  • PRPO N/A
  • DSS N/A
  • EPS
  • PRPO N/A
  • DSS N/A
  • Revenue
  • PRPO $17,411,000.00
  • DSS $25,019,000.00
  • Revenue This Year
  • PRPO $75.18
  • DSS N/A
  • Revenue Next Year
  • PRPO N/A
  • DSS N/A
  • P/E Ratio
  • PRPO N/A
  • DSS N/A
  • Revenue Growth
  • PRPO 31.31
  • DSS N/A
  • 52 Week Low
  • PRPO $4.31
  • DSS $0.77
  • 52 Week High
  • PRPO $7.55
  • DSS $2.30
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 62.56
  • DSS 56.49
  • Support Level
  • PRPO $7.02
  • DSS $0.81
  • Resistance Level
  • PRPO $7.55
  • DSS $0.97
  • Average True Range (ATR)
  • PRPO 0.25
  • DSS 0.07
  • MACD
  • PRPO 0.05
  • DSS 0.01
  • Stochastic Oscillator
  • PRPO 73.78
  • DSS 81.82

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

Share on Social Networks: